Esther M. John

76.4k citations
464 papers · 20.6k · 5 hit papers · h-index 72

Impact in

  • Oncology top 0.1%
    • Cancer Risks and Factors
    • Global Cancer Incidence and Screening
    • Ovarian cancer diagnosis and treatment

Papers in

    • Cancer Risks and Factors 99
    • Global Cancer Incidence and Screening 65
    • BRCA gene mutations in cancer 116
    • Genetic Associations and Epidemiology 31

Esther M. John

447 papers receiving 19.8k citations

Esther M. John's Hit Papers

Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer 2009 · 766 citations
7660+12+25Years since publication2505007501000

Peers

Esther M. John
Comparison fields: 5 of 196
  • Oncology 7.3k
  • Reproductive Medicine 2.1k
  • Cancer Research 3.7k
  • Genetics 6.4k
  • Pathology and Forensic Medicine 3.0k
Replace Graham G. Giles with:
Graham G. Giles Australia
­Eero Pukkala Finland
Jørgen H. Olsen Denmark
Anthony J. Swerdlow United Kingdom
John D. Boice United States
Susan S. Devesa United States
Robert N. Hoover United States
Valerie Beral United Kingdom
Adèle C. Green Australia
Laurence N. Kolonel United States
Esther M. John relative to Graham G. Giles Australia Graham G. Giles's profile →
Citations per field
00.5×1.5×2.5×
Graham G. Giles · 1×
Citations per year

Countries citing papers authored by Esther M. John

Since Specialization
Citations

This map shows the geographic impact of Esther M. John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther M. John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther M. John more than expected).

Fields of papers citing papers by Esther M. John

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther M. John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther M. John. The network helps show where Esther M. John may publish in the future.

Co-authors

The 25 scholars most cited alongside Esther M. John, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Esther M. John Line = papers co-authored together Esther M. John links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 464 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Reproductive Factors and Breast Cancer
Hit paper breakdown →
19931102
2
Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer
Hit paper breakdown →
2009766
3
Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian Cancer
Hit paper breakdown →
2001730
4
CASE-CONTROL STUDY OF CHILDHOOD CANCER AND EXPOSURE TO 60-HZ MAGNETIC FIELDS
Hit paper breakdown →
1988567
5
Prostate Cancer in Relation to Diet, Physical Activity, and Body Size in Blacks, Whites, and Asians in the United States and Canada
Hit paper breakdown →
1995500
6 2006497
7 1986438
8 2006421
9
Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study.
2000364
10 2011295
11
Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey.
1999266
12 2007250
13 1995213
14 2004205
15 2000195
16 1977194
17 2005184
18
Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada.
1996169
19 2005168
20 1991161

About Esther M. John

Esther M. John is a scholar working on Oncology, Genetics, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 464 papers that have together received 20.6k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (116 papers), Cancer Risks and Factors (99 papers), Global Cancer Incidence and Screening (65 papers), Breast Cancer Treatment Studies (38 papers), Nutritional Studies and Diet (34 papers), Cancer Genomics and Diagnostics (34 papers), Ovarian cancer diagnosis and treatment (31 papers) and Genetic Associations and Epidemiology (31 papers). The work is most often cited by research in Oncology (7.3k citations), Reproductive Medicine (2.1k citations), Cancer Research (3.7k citations), Genetics (6.4k citations) and Pathology and Forensic Medicine (3.0k citations). Esther M. John has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Marilie D. Gammon, Jocelyn Koo, Jennifer L. Kelsey, Alice S. Whittemore, Steven A. Narod, David A. Savitz, Barry P. Rosen, Dee W. West, Harvey A. Risch and Gary G. Schwartz. Their work appears in journals such as Cancer Epidemiology Biomarkers & Prevention, Breast Cancer Research and Treatment, Journal of Clinical Oncology, Cancer Causes & Control and Breast Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact